![]() |
| |
| |
| |
| |
| |
| |
|
| TissGeneSummary for SHISA2 |
Gene summary |
| Basic gene information | Gene symbol | SHISA2 |
| Gene name | shisa family member 2 | |
| Synonyms | C13orf13|PRO28631|TMEM46|WGAR9166|bA398O19.2|hShisa | |
| Cytomap | UCSC genome browser: 13q12.13 | |
| Type of gene | protein-coding | |
| RefGenes | NM_001007538.1, | |
| Description | protein shisa-2 homologshisa homolog 2transmembrane protein 46 | |
| Modification date | 20141207 | |
| dbXrefs | HGNC : HGNC | |
| Ensembl : ENSG00000180730 | ||
| HPRD : 16589 | ||
| Vega : OTTHUMG00000016612 | ||
| Protein | UniProt: go to UniProt's Cross Reference DB Table | |
| Expression | CleanEX: HS_SHISA2 | |
| BioGPS: 387914 | ||
| Pathway | NCI Pathway Interaction Database: SHISA2 | |
| KEGG: SHISA2 | ||
| REACTOME: SHISA2 | ||
| Pathway Commons: SHISA2 | ||
| Context | iHOP: SHISA2 | |
| ligand binding site mutation search in PubMed: SHISA2 | ||
| UCL Cancer Institute: SHISA2 | ||
| Assigned class in TissGDB* | C | |
| Included tissue-specific gene expression resources | TiGER,GTEx | |
| Specific-tissues in normal samples (assigned by TissGDB using HPA, TiGER, and GTEx) | KidneyThyroid gland | |
| Cancer types related to the specific-tissues in cancer samples (assigned by TissGDB using TCGA) | KIRC,KIRP,KICHTHCA | |
| Reference showing the relevant tissue of SHISA2 | ||
| Description by TissGene annotations | ||
| * Class A consists of genes with literature evidence and is part of the cTissGenes. Class B consists of only cTissGenes without additional evidence. The remaining genes belong to Class C. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
| GO ID | GO term | PubMed ID |
| Top |
| TissGeneExp for SHISA2 |
Gene expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
![]() |
Gene isoform expressions across 28 cancer types (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA pan-cancer tcga_rsem_isoform_tpm, version 2016-09-01) |
![]() |
Gene expressions across normal tissues of GTEx data(GTEx GTEx_Analysis_v6_RNA-seq_RNA-SeQCv1.1.8_gene_rpkm.gct) - Here, we shows the matched tissue types only among our 28 cancer types. |
![]() |
Different expressions across 14 cancer types with more than 10 samples between matched tumors and normals (X-axis: cancer type and Y-axis: log2(norm_counts+1))(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) |
![]() |
| - Significantly differentially expressed cancer types and information. (|Fold change|>1 and FDR<0.05) |
| Cancer type | Mean(exp) in tumor | Mean(exp) in matched normal | Log2FC | P-val. | FDR |
| LUAD | 0.041702569 | 1.530880155 | -1.489177586 | 2.82E-06 | 8.76E-06 |
| COAD | -0.507203798 | -3.380515336 | 2.873311538 | 1.61E-10 | 2.15E-09 |
| KIRC | -2.642526981 | 0.907936908 | -3.550463889 | 7.75E-28 | 1.21E-26 |
| KIRP | -0.568839134 | 0.610229616 | -1.17906875 | 0.00345 | 0.008416649 |
| HNSC | 0.660219369 | -0.694999236 | 1.355218605 | 0.00261 | 0.007757596 |
| Top |
| TissGene-miRNA for SHISA2 |
Significantly anti-correlated miRNAs of TissGene across 28 cancer types(Gene-miRNA relations from TargetScanHuman Relsease 7.1, Conserved_Site_Context_Scores.txt.zip, 06.01.2016) (TCGA IlluminaHiSeq_miRNASeq, log2(RPM+1) data, version 2016-11-21) (TCGA IlluminaHiSeq_RNASeqV2, log2(normalized_count+1) data, version 2016-08-16) (Spearman’s Rank Correlation (p-value<0.05 and coefficient<-0.25)) |
| Cancer type | miRNA id | miRNA accession | P-val. | Coeff. | # samples |
| Top |
| TissGeneMut for SHISA2 |
| TissGeneSNV for SHISA2 |
nsSNV counts per each loci.Different colors of circles represent different cancer types. Circle size denotes number of samples. (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) * Click on the image to enlarge it in a new window. |
![]() |
![]() |
Somatic nucleotide variants of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of mutated samples) The numbers in parentheses are numbers of samples with mutation (nsSNVs). (TCGA somatic mutation (SNPs and small INDELs) data, version 2016-04-25) |
![]() |
| - nsSNVs sorted by frequency. |
| AAchange | Cancer type | # samples |
| p.G60D | PCPG | 3 |
| p.V116M | STAD | 1 |
| p.R174Q | SKCM | 1 |
| p.C207F | LUSC | 1 |
| p.A127T | GBM | 1 |
| p.Q277H | KIRP | 1 |
| p.S178L | SKCM | 1 |
| p.C207F | UCEC | 1 |
| p.Q277* | SKCM | 1 |
| p.N158S | STAD | 1 |
| p.A195T | SKCM | 1 |
| p.T163I | PRAD | 1 |
| p.A197V | UCEC | 1 |
| p.P209T | ESCA | 1 |
| p.G240W | LUAD | 1 |
| p.T251M | LUAD | 1 |
| p.A292V | PRAD | 1 |
| p.Q150H | LUAD | 1 |
| p.R159C | UCEC | 1 |
| p.S7W | UCS | 1 |
| p.P258L | LUAD | 1 |
| p.N284S | UCEC | 1 |
| p.S176L | STAD | 1 |
| p.P149L | SKCM | 1 |
| p.Q231* | UCEC | 1 |
| p.R174W | BRCA | 1 |
| p.V126D | COAD | 1 |
| p.Q239* | SKCM | 1 |
| p.G268D | STAD | 1 |
| p.V116M | BLCA | 1 |
| p.S123F | CESC | 1 |
| p.I130M | LUSC | 1 |
| p.S152I | LUAD | 1 |
| p.I167N | STAD | 1 |
| p.T163I | UCEC | 1 |
| p.P237S | LUAD | 1 |
| p.S176L | PCPG | 1 |
| p.P149S | SKCM | 1 |
| p.V252M | STAD | 1 |
| p.D255N | SKCM | 1 |
| p.E210K | STAD | 1 |
| p.Y242H | SKCM | 1 |
| Top |
| TissGeneCNV for SHISA2 |
Copy number variations of TissGene across 28 cancer types (X-axis: cancer type and Y-axis: % of CNV samples)(TCGA Gistic2_CopyNumber_Gistic2_all_data_by_genes, Gistic2 copy number data, version 2016-08-16) |
![]() |
| Top |
| TissGeneFusions for SHISA2 |
Fusion genes including TissGene (ChimerDB 3.0, 2016-12-01 and TCGA fusion Portal 2015-12-01) |
| Database | Src | Cancer type | Sample | Fusion gene | ORF | 5'-gene BP | 3'-gene BP |
| Top |
| TissGeneNet for SHISA2 |
Co-expressed gene networks based on protein-protein interaction data (CePIN)(TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (PINA2 ppi data) |
| Top |
| TissGeneProg for SHISA2 |
Kaplan-Meier plots with logrank tests of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image to enlarge it in a new window. |
![]() |
Kaplan-Meier plots with logrank test of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of overall survival (OS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
Forest plot of Cox proportional hazard ratio (HR) and 95% CI of relapse free survival (RFS) using 28 cancer types (TCGA IlluminaHiSeq_RNASeqV2, pan-cancer normalized log2(norm_counts+1) data, version 2016-08-16) (TCGA clinicalMatrix, phenotype data, version 2016-04-27) * Click on the image enlarge it in a new window. |
![]() |
| Top |
| TissGeneClin for SHISA2 |
| TissGeneDrug for SHISA2 |
Drug information targeting TissGene (DrugBank Version 5.0.6, 2017-04-01) |
| DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
| Top |
| TissGeneDisease for SHISA2 |
Disease information associated with TissGene (DisGeNet, 2016-06-01) |
| Disease ID | Disease name | # pubmeds | Source |
| umls:C0002395 | Alzheimer's Disease | 1 | GAD |
| umls:C0002736 | Amyotrophic Lateral Sclerosis | 1 | GAD |